Avisi Technologies

📍 Redwood City, United States🗓 Founded 2017👥 16 employees💰 Last funded Sep 2022
Avisi is a medical devices startup investigating the use of patented nanotechnology in an ocular implant to stop blindness in glaucoma patients. Glaucoma is the second leading cause of blindness in the world and currently has no cure. To date, Avisi has been supported by grants and awards from: the National Science Foundation, Ben Franklin Technology Partners, the University of Pennsylvania, Wharton, The School of Engineering and Applied Science, Venture Initiation Program Accelerator (VIP-X), Penn Law's Entrepreneurship Legal Clinic, VentureWell E-Teams, and Ballard Spahr BASE. Avisi is a proud member of Johnson & Johnson JLABS incubator, UCSF Rosenman Innovators, OC OCTANE LaunchPad, and MedTech Innovator Accelerator. Twitter: @avisi_tech Website: www.avisitech.com
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Avisi Technologies?
Avisi Technologies has 1 investors on record on gritt.io, 1 mid-stage.
When did Avisi Technologies last raise funding?
The most recent investment in Avisi Technologies recorded on gritt.io was in September 2022.
When was Avisi Technologies founded?
Avisi Technologies was founded in 2017.
What industry is Avisi Technologies in?
Avisi Technologies operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Avisi Technologies based?
Avisi Technologies is headquartered in Redwood City, United States.